The FARE Capital Impact Fund has launched through its first investment in My Life Technologies.

To earmark this joyful occasion, Mike de Leeuw, CEO of My Life Technologies, sounded the opening bell at Euronext Amsterdam.

My Life Technologies is a highly innovative enterprise, that is developing a vaccine technology based on vaccin delivery through ceramic skin patches, as opposed to traditional injections.

Please see the press release that accompanied this investment round.

MyLife Technologies raises US$4.0 million to develop its vaccine delivery technology through painless ceramic vaccine patches def